Sun Pharma's Q2 nos draw price upgrades, stock hits 7-yr high https://ift.tt/YzEmcTA of India's largest pharmaceutical company, which surged to its seven-year high earlier on Wednesday, advanced 1.45% to close at ₹1,051.60. It touched a high of ₹1,070.95 before giving up some of its gains. Analysts have a median target price of ₹1,135.28 per share. That translates roughly into gains of 8.3% from the current market price.
NSE IFSC-SGX Connect may be fully operational by June https://ift.tt/XC89Iks this connectivity, global investors who are clients of SGX will be able to trade in Indian derivatives market remotely without having to set up a shop in India. Currently, only a few trades are being executed through the route.
Comments
Post a Comment